Bleichroeder LP’s DiaMedica Therapeutics DMAC Stock Holding History

Bleichroeder LP’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.59M	Hold	382,317	–	–	0.45%	29
2025 Q4	$3.04M	Hold	382,317	–	–	0.54%	23
2025 Q3	$2.63M	Hold	382,317	–	–	0.51%	25
2025 Q2	$1.49M	Hold	382,317	–	–	0.37%	25
2025 Q1	$1.45M	Hold	382,317	–	–	0.39%	24
2024 Q4	$2.08M	Hold	382,317	–	–	0.52%	20
2024 Q3	$1.6M	Hold	382,317	–	–	0.43%	25
2024 Q2	$1.13M	Buy	382,317 +160,000	+72%	+$439K	0.34%	29
2024 Q1	$616K	Hold	222,317	–	–	0.15%	37
2023 Q4	$631K	Hold	222,317	–	–	0.14%	33
2023 Q3	$574K	Sell	222,317 -71,800	-24%	-$231K	0.14%	30
2023 Q2	$1.27M	Buy	+294,117	New	+$714K	0.26%	32

Other funds holding DMAC

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bleichroeder LP's DMAC Position: Q1 2026 in Review

Bleichroeder LP held its DiaMedica Therapeutics (DMAC) position steady in Q1 2026 at 382,317 shares worth $2.59M. The position accounts for 0.45% of the portfolio, ranked #29.

Bleichroeder LP first reported a position in DMAC in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.04M in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

Bleichroeder LP held 382,317 shares of DiaMedica Therapeutics worth $2.59M as of Q1 2026.
Bleichroeder LP left its DiaMedica Therapeutics share count unchanged in Q1 2026.
DiaMedica Therapeutics made up 0.45% of Bleichroeder LP's portfolio in Q1 2026, its #29 holding.
Bleichroeder LP first reported a position in DiaMedica Therapeutics in Q2 2023 and has held it in 12 quarters since.
Bleichroeder LP's DiaMedica Therapeutics position peaked at $3.04M in Q4 2025.
98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.